Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Academic Hospital
12%
AIDS/HIV
11%
Apoptosis
6%
Atorvastatin
5%
Blood Glucose
9%
Body Mass Index
7%
Chronic Kidney Disease
9%
Chronic Kidney Disease Patients
5%
Clinical Outcomes
6%
Confidence Interval
9%
COVID-19
31%
COVID-19 Pandemic
11%
COVID-19 Patients
6%
Diabetes
5%
East Java Indonesia
7%
Ethanol Extract
9%
Factor Level
6%
Fasting Plasma Glucose
5%
Gene Polymorphism
5%
General Hospital
7%
Genotype
7%
Glucose-6-phosphate Dehydrogenase (G6PD)
6%
Healthcare Workers
5%
Hepatitis B Virus
14%
Hepatitis C Virus
9%
High-intensity Interval Training
5%
In Vitro Study
5%
Inclusion Criteria
7%
Indonesia
100%
Indonesian
18%
Inflammation
11%
Inflammatory Cytokines
8%
Interleukin-6
11%
Leaf Extract
11%
Leprosy
5%
Liver
5%
Malaysian Adults
5%
Malondialdehyde
7%
Malondialdehyde Level
5%
Meta-analysis
27%
Methotrexate
5%
Moderate Intensity
10%
Mouse Model
5%
Mouse Mus musculus
7%
Negative Control
5%
No Significant Difference
8%
Obese Women
10%
Obesity
8%
Odds Ratio
5%
Optical Coherence Tomography
5%
Outpatient Clinic
9%
Oxidative Stress
11%
Pediatric
5%
Plasmodium Falciparum
6%
Preeclampsia
14%
Pregnant Women
12%
Protective Effect
5%
PubMed
7%
Rat Model
9%
Rattus Norvegicus
13%
Referral Hospital
5%
Risk Factors
13%
Statistical Analysis
8%
Surabaya
57%
Systematic Meta-analysis
24%
Systemic Lupus Erythematosus
5%
Tertiary Hospital
5%
Tertiary Referral Hospital
5%
Traumatic Brain Injury
9%
Treatment Group
12%
Tumor Necrosis Factor-α
12%
Type 1 Diabetes Mellitus (T1DM)
8%
Type 2 Diabetes Mellitus (T2DM)
5%
Wistar Rats
10%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
6%
Antimalarial Agent
5%
Antioxidant
9%
Biological Marker
6%
Caspase 3
5%
Cerebrovascular Accident
6%
Chronic Kidney Failure
8%
Cohort Study
5%
Coronavirinae
12%
Cross-Sectional Study
11%
Cytokine
9%
Diabetes Mellitus
12%
Diseases
31%
Enzyme-Linked Immunosorbent Assay
7%
Hemodialysis
5%
Hepatitis B Virus
11%
Hepatitis C Virus
7%
HIV
11%
Infection
22%
Inflammation
23%
Interleukin 6
12%
Malignant Neoplasm
5%
Malonaldehyde
9%
Mouse Model
6%
Non Insulin Dependent Diabetes Mellitus
5%
Observational Study
5%
Pandemic
7%
Preeclampsia
8%
Prevalence
16%
Randomized Controlled Trial
5%
Rat Model
12%
Rattus norvegicus
11%
Retrospective Study
8%
Side Effect
6%
Streptozotocin
6%
Traumatic Brain Injury
9%
Treatment Group
14%
Tumor Necrosis Factor
17%
Wistar Rat
13%
Medicine and Dentistry
Biological Marker
6%
Blood Glucose
6%
Chronic Kidney Disease
8%
COVID-19
32%
Cross Sectional Study
15%
Dermatology
6%
Diabetes Mellitus
6%
Diseases
16%
Health Care Cost
6%
Human Immunodeficiency Virus
7%
In Vitro
5%
Infection
17%
Lymphocyte
6%
Medical Record
5%
Meta-Analysis
20%
Observational Study
6%
Obstetrics
6%
Odds Ratio
5%
Optical Coherence Tomography
6%
Outpatient
13%
Oxidative Stress
5%
Patient Referral
11%
Pediatrics
9%
Pre-Eclampsia
14%
Prevalence
10%
Programmed Cell Death
5%
Quality of Life
5%
Randomized Controlled Trial
5%
Retrospective Study
12%
Systematic Review
31%
Traumatic Brain Injury
5%
Treatment Group
5%
Tumor Necrosis Factor
8%
Venereology
5%